Wei Jiang

ORCID: 0000-0001-5408-6055
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Ovarian cancer diagnosis and treatment
  • Endometrial and Cervical Cancer Treatments
  • Uterine Myomas and Treatments
  • Cardiac Health and Mental Health
  • Electroconvulsive Therapy Studies
  • Endometriosis Research and Treatment
  • Treatment of Major Depression
  • Intraperitoneal and Appendiceal Malignancies
  • Monoclonal and Polyclonal Antibodies Research
  • Toxin Mechanisms and Immunotoxins
  • Cancer Mechanisms and Therapy
  • Cardiovascular Issues in Pregnancy
  • Glioma Diagnosis and Treatment
  • Heart Failure Treatment and Management
  • HIV, Drug Use, Sexual Risk
  • HIV, TB, and STIs Epidemiology
  • Sarcoma Diagnosis and Treatment
  • Brain Metastases and Treatment
  • Testicular diseases and treatments
  • Pelvic and Acetabular Injuries
  • Hernia repair and management
  • 14-3-3 protein interactions
  • Chemokine receptors and signaling
  • Gestational Trophoblastic Disease Studies
  • Liver Disease Diagnosis and Treatment

Obstetrics and Gynecology Hospital of Fudan University
2014-2024

Beijing Anding Hospital
2019-2022

Capital Medical University
2019-2022

First Affiliated Hospital of Jinan University
2021

Brigham and Women's Hospital
2016-2020

Medtronic (United States)
2018

Harvard University
2018

Duke University Health System
2017

The First People's Hospital of Changzhou
2017

Bozhou People's Hospital
2015

Background: Patients with congestive heart failure (CHF) may have a high prevalence of depression, which increase the risk adverse outcomes.Objective: To determine and relationship depression to outcomes patients hospitalized CHF. Methods:We screened aged 18 years or older having New York Heart Association class II greater CHF, an ejection fraction 35% less, both, admitted between March 1, 1997, June 30, 1998, cardiology service one hospital.Patients Beck Depression Inventory score 10 higher...

10.1001/archinte.161.15.1849 article EN Archives of Internal Medicine 2001-08-13

Background: Preoperative opioid use is known to increase the likelihood of complications and inferior outcomes following spine surgery. We evaluated association preoperative other risk factors with postoperative use. Methods: queried 2006-2014 TRICARE insurance claims identify adults who underwent lumbar interbody arthrodesis, discectomy, decompression, or posterolateral arthrodesis. The duration was categorized as acute exposure, exposed without sustained use, intermediate chronic Cox...

10.2106/jbjs.17.00862 article EN Journal of Bone and Joint Surgery 2018-06-06

10.1016/j.jpag.2013.07.007 article EN Journal of Pediatric and Adolescent Gynecology 2013-10-21

Insulin degrading enzyme (IDE) is believed to act as a junction point of Type 2 diabetes (T2D) and Alzheimer's disease (AD); however, the underlying mechanism was not completely clear yet. Transgenic APPSwe/PS1 mice were used AD model treated with streptozocin/streptozotocin (STZ) develop mixed presenting both T2D. Morris Water Maze (MWM) recognition task performed trace cognitive function. The detection fasting plasma glucose (FPG) insulin concentration, oral tolerance test (OGTT)...

10.1042/bsr20170862 article EN cc-by Bioscience Reports 2017-12-09

Although there is evidence that changes in clinicians during the continuum of care (care discontinuity) are associated with higher mortality and complications among surgical patients, little known regarding drivers discontinuity emergency general surgery (EGS) patients.To identify hospital factors EGS patients.We performed a retrospective analysis 100% Medicare inpatient claims file, from January 1, 2008, to November 30, 2011, matched patient details information 2011 American Hospital...

10.1001/jamasurg.2016.4078 article EN JAMA Surgery 2016-11-16

Plexiform neurofibromas (PNFs) are benign nerve sheath tumors mostly associated with neurofibromatosis type 1. They often extend through multiple layers of tissue and therefore cannot be treated satisfactorily by surgery. Nilotinib is a tyrosine kinase inhibitor used to treat leukemia, advantages over the prototype imatinib in terms potency selectivity towards BCR-ABL, DDR, PDGFR, KIT receptor kinases. In this study, we compared efficacies two drugs on cultured cells PNF vitro xenografted...

10.1371/journal.pone.0107760 article EN cc-by PLoS ONE 2014-10-23

To evaluate the effect of tetramethylpyrazine (TMP) on laser-induced experimental choroidal neovascularization (CNV) in rat model vivo and endothelial cell proliferation vitro.Male Brown Norway rats were anesthetized to receive Nd:YAG laser break Bruch membrane. TMP was given once daily through intraperitoneal injection after treatment for 4 weeks. The development CNV determined by angiography performed week 2 using sodium fluorescein (FA) or isothiocyanate-dextran (FD70-FA). Human umbilical...

10.1080/02713680601088787 article EN Current Eye Research 2007-01-01

As ovarian clear cell carcinoma (OCCC) has distinct clinical features, biology, genetic characteristics and mechanisms of pathogenesis, whether the origin endometriosis or not affects prognosis OCCC remains controversial.We retrospectively collected medical records follow-up data patients with treated at Obstetrics Gynecology Hospital Fudan University from January 2009 to December 2019. Further, we divided into 2 groups. Group 1: non-endometriosis origin; 2: origin. Clinicopathological...

10.1007/s12672-023-00649-8 article EN cc-by Discover Oncology 2023-04-01

We previously identified platelet-activating factor receptor (PAFR) as being overexpressed in ovarian cancer and found that its ligand PAF evoked EGFR phosphorylation using the phospho-antibody microarray. Epidermal growth (EGFR) are also contribute to of cells. Here, we investigated mechanisms crosstalk between PAFR signaling cells further determine whether interaction synergistic progression cancer. Expression localization several cell lines were assessed by Western blot, realtime-PCR...

10.1186/preaccept-3141194111370796 article EN cc-by Journal of Experimental & Clinical Cancer Research 2014-01-01
Coming Soon ...